지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Osteoarthritis (OA) is a common chronic degenerative disease, and its prevalence increases with age. For patients with symptomatic OA, pharmacological treatment is suggested if symptoms and function do not improve with nonpharmacological modalities, including exercise, devices, manual therapy, or self-management programs. Attempts have been made to develop medications that prevent the structural progression of OA; however, the pharmacological treatment of OA has focused on the management of pain to improve the functional ability of joints. Clinicians try to prescribe adequate classes and doses of medications for pain relief, considering the affected parts of joints, each patient’s comorbidities, and the clinical response to medical treatment, including tolerability and side effects. It is important to titrate the dose of medications as patients’ symptoms change over time, maintaining the lowest effective dose for each individual.
목차
등록된 정보가 없습니다.
참고문헌 (3)
참고문헌 신청
조남한 / 2007 / 지역사회에서 손 골관절염과 무릎 골관절염의 유병률 및 위험인자 / 대한류마티스학회지 14(4):354~362
김형영 / 2018 / Impact of Osteoarthritis on Household Catastrophic Health Expenditures in Korea / Journal of Korean Medical Science 33(21):1~11
김담 / 2017 / Cardiovascular and Gastrointestinal Effects of Etoricoxib in the Treatment of Osteoarthritis: A Systematic Review and Network Meta-analysis / 대한류마티스학회지 24(5):293~302
김형영 / 2018 / Impact of Osteoarthritis on Household Catastrophic Health Expenditures in Korea / Journal of Korean Medical Science 33(21):1~11
김담 / 2017 / Cardiovascular and Gastrointestinal Effects of Etoricoxib in the Treatment of Osteoarthritis: A Systematic Review and Network Meta-analysis / 대한류마티스학회지 24(5):293~302
이 논문의 저자 정보
최근 본 자료
댓글(0)
0